FDA Adverse Event Malfunction Summary report: N

SPACEOAR VUE SYSTEM

MDR report key: 20417685 · Received October 10, 2024

Report

Report Number
2124215-2024-63139
Event Type
Malfunction
Date Received
October 10, 2024
Date of Event
September 10, 2024
Report Date
July 22, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
OVB
PMA / PMN Number
K182971
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK H6: DEVICE CODE A1502 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF GEL MISPLACED NON-VASCULAR. BLOCK H11: BLOCK B5, AND B6 (IMPACT CODES) WERE UPDATED BASED ON ADDITIONAL INFORMATION RECEIVED ON 20NOV2024.

Additional Manufacturer Narrative · 0

BLOCK H6: DEVICE CODE A1502 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF GEL MISPLACED NON-VASCULAR.

Additional Manufacturer Narrative · 0

BLOCK H6: DEVICE CODE A1502 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF GEL MISPLACED NON-VASCULAR. BLOCK H11: BLOCK B5 WAS UPDATED BASED ON ADDITIONAL INFORMATION RECEIVED ON JUNE 27,2025. CLINICAL STUDY NAME: (B)(6).

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT WHO UNDERWENT A SPACE OAR INJECTION AND FIDUCIAL MARKERS PLACEMENT UNDER GENERAL ANESTHESIA EXPERIENCED A RECTAL WALL INFILTRATION. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. TWO MONTHS LATER, THE PATIENT REMAINS ASYMPTOMATIC AND IS SCHEDULED FOR FURTHER MEDICAL CHECKS, INCLUDING A FLEXIBLE SIGMOIDOSCOPY AND MAGNETIC RESONANCE IMAGING (MRI).

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT WHO UNDERWENT A SPACE OAR INJECTION AND FIDUCIAL MARKERS PLACEMENT UNDER GENERAL ANESTHESIA EXPERIENCED A RECTAL WALL INFILTRATION. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT WHO UNDERWENT A SPACE OAR INJECTION AND FIDUCIAL MARKERS PLACEMENT UNDER GENERAL ANESTHESIA EXPERIENCED A RECTAL WALL INFILTRATION. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. TWO MONTHS LATER, THE PATIENT REMAINS ASYMPTOMATIC AND IS SCHEDULED FOR FURTHER MEDICAL CHECKS, INCLUDING A FLEXIBLE SIGMOIDOSCOPY AND MAGNETIC RESONANCE IMAGING (MRI). ADDITIONAL INFORMATION, IT WAS REPORTED THAT THE PATIENT DID NOT COMPLETE THE STEREOTACTIC BODY RADIATION THERAPY (SBRT) TREATMENT; INSTEAD, COMPLETED AN ALTERNATE COURSE OF VOLUMETRIC MODULATED ARC THERAPY (VMAT) TREATMENT, COMPLETED ON (B)(6) 2025.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2004956 SPACEOAR VUE SYSTEM ABSORBABLE PERIRECTAL SPACER OVB BOSTON SCIENTIFIC CORPORATION SV-1010 0031939046

Patients

Seq Age Sex Outcome Treatment
1 67 YR Male